Search - tctmd.com

Displaying 61 - 80 of 128

Sort: Relevancy | Date

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Duration of Intra-Aortic Entrainment Pump Therapy and Clinical Outcomes in Acute Decompensated Heart Failure and Cardiorenal Syndrome

Presenter: Matteo Fabbri

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Presenter: Eduardo Arias

March 05, 2024

Presentation THT Abstracts 2024

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Right Ventricular Preservation with Implant-Free Interatrial Shunt

Presenter: Saibal Kar

March 05, 2024

Presentation THT Abstracts 2024

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

Presenter: David Golombeck

March 05, 2024

Presentation THT Abstracts 2024

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Presenter: Daniel Bensimhon

March 05, 2024

Presentation THT Abstracts 2024

Use of EMR-Based Clinical Workflows Improves Access and Equity for Patients with Advanced Heart Failure 2013 A Single Center Experience

March 05, 2024

Presentation THT Abstracts 2024

Microtech Left Atrial Pressure Monitoring Submillimeter Sensor & System

Presenter: Yoram Richter

March 05, 2024

Presentation THT Abstracts 2024

Guideline-Directed Heart Failure Therapy in HeartMate 3 Patients

Presenter: Changhee Lee

March 05, 2024

Presentation THT Abstracts 2024

Longitudinal Near-Infrared Spectroscopy Intravascular Ultrasound Assessment of Donor-transmitted Lipid Content and Plaque Volume in Coronary Arteries after Heart Transplantation

Presenter: Tatsuya Shiraki

March 05, 2024

Presentation THT Abstracts 2024

Sex Differences in Acute Heart Failure Related Cardiogenic Shock

Presenter: Rebecca Smoller

March 05, 2024

Presentation THT Abstracts 2024

Newly Developed Cardiogenic Shock Team: 10 month update

Presenter: Robin Miller

March 05, 2024

Presentation THT Abstracts 2024

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Presenter: Daniel Snyder

March 05, 2024

Presentation THT Abstracts 2024

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Cardiogenic Shock in the Community 2013 Outcomes of Cardiogenic Shock at a tertiary, non-durable VAD, non-transplant care center†

Presenter: Chirag Mehta

March 05, 2024

Presentation THT Abstracts 2024

Sex and race differences in objective measures of frailty, provider assessed frailty, and associated outcomes: an Intermacs registry analysis

Presenter: Rebecca Steinberg

March 05, 2024

Advertisement

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Duration of Intra-Aortic Entrainment Pump Therapy and Clinical Outcomes in Acute Decompensated Heart Failure and Cardiorenal Syndrome

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Right Ventricular Preservation with Implant-Free Interatrial Shunt

Central and Peripheral Determinants of Exercise with the HeartMate 3TM LVAD

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Use of EMR-Based Clinical Workflows Improves Access and Equity for Patients with Advanced Heart Failure 2013 A Single Center Experience

Microtech Left Atrial Pressure Monitoring Submillimeter Sensor & System

Guideline-Directed Heart Failure Therapy in HeartMate 3 Patients

Longitudinal Near-Infrared Spectroscopy Intravascular Ultrasound Assessment of Donor-transmitted Lipid Content and Plaque Volume in Coronary Arteries after Heart Transplantation

Sex Differences in Acute Heart Failure Related Cardiogenic Shock

Newly Developed Cardiogenic Shock Team: 10 month update

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Cardiogenic Shock in the Community 2013 Outcomes of Cardiogenic Shock at a tertiary, non-durable VAD, non-transplant care center†

Sex and race differences in objective measures of frailty, provider assessed frailty, and associated outcomes: an Intermacs registry analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content